🔴 MBX Biosciences is trading 4.37% down today amid a 19-year-high 10-year Treasury yield

MBX Biosciences is trading 4.37% lower at $55.36 as broader risk-off pressure weighs on biotechnology and growth stocks.

• The Nasdaq is down 0.87%, while biotechnology ETF XBI is down 2.04%.
• The 10-year Treasury yield reached 5.14%, a 19-year high, raising concerns about persistent inflation and higher-for-longer interest rates.
• No new company-specific announcement was identified; the latest investor-relations release was September 9.